Advertisement
Advertisement

BVS

BVS logo

Bioventus Inc. Class A Common Stock

9.63
USD
Sponsored
+0.13
+1.34%
Jun 25, 11:17 UTC -4
Open

BVS Earnings Reports

Positive Surprise Ratio

BVS beat 16 of 22 last estimates.

73%

Next Report

Date of Next Report
Aug 04, 2026
Estimate for Q2 26 (Revenue/ EPS)
$157.00M
/
$0.22
Implied change from Q1 26 (Revenue/ EPS)
+18.86%
/
+46.67%
Implied change from Q2 25 (Revenue/ EPS)
+6.33%
/
+4.76%

Bioventus Inc. Class A Common Stock earnings per share and revenue

On May 06, 2026, BVS reported earnings of 0.15 USD per share (EPS) for Q1 26, beating the estimate of 0.09 USD, resulting in a 52.28% surprise. Revenue reached 132.09 million, compared to an expected 131.15 million, with a 0.72% difference. The market reacted with a +2.25% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 4 analysts forecast an EPS of 0.22 USD, with revenue projected to reach 157.00 million USD, implying an increase of 46.67% EPS, and increase of 18.86% in Revenue from the last quarter.
FAQ
For Q1 2026, Bioventus Inc. Class A Common Stock reported EPS of $0.15, beating estimates by 52.28%, and revenue of $132.09M, 0.72% above expectations.
The stock price moved up 2.25%, changed from $10.68 before the earnings release to $10.92 the day after.
The next earning report is scheduled for Aug 04, 2026.
Based on 4 analysts, Bioventus Inc. Class A Common Stock is expected to report EPS of $0.22 and revenue of $157.00M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement